TickerFactsScreenerDevelopers

Rein Therapeutics, Inc. (RNTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: -$82.04M2015: -$94.32M2016: -$111.81M2017: $47.80M2018: $19.60M2019: $16.05M2020: $12.16M2021: $43.90M2022: $18.62M2023: $98.30M2024: $54.39M2025: $16.92M$16.92M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$16.92M-68.9%
2024$54.39M-44.7%
2023$98.30M+427.8%
2022$18.62M-57.6%
2021$43.90M+261.0%
2020$12.16M-24.2%
2019$16.05M-18.1%
2018$19.60M-59.0%
2017$47.80M+142.7%
2016-$111.81M-18.5%
2015-$94.32M-15.0%
2014-$82.04M—